NCT05891171 2026-03-31
ARC-25
Arcus Biosciences, Inc.
Phase 1 Active not recruiting
Arcus Biosciences, Inc.
Merck Sharp & Dohme LLC
Institut du Cancer de Montpellier - Val d'Aurelle
University of California, Irvine
University of Chicago
Stanford University